Next generation Glucose-1-phosphate thymidylyltransferase (RmlA) inhibitors: An extended SAR study to direct future design. (2021)
Attributed to:
Structural Biology in the RFI
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bmc.2021.116477
PubMed Identifier: 34757294
Publication URI: http://europepmc.org/abstract/MED/34757294
Type: Journal Article/Review
Volume: 50
Parent Publication: Bioorganic & medicinal chemistry
ISSN: 0968-0896